Whether you are a tech optimist or not, you have to acknowledge that progress rarely follows a straight line. Some hope that AI can help, and it likely will— when it comes to biotech, it is much more than a buzzword. But Boston-based drug discovery startup Pepper Bio fell in love with another term: Transomics.

Cientistas brasileiros desenvolveram algoritmos de inteligência artificial (IA) que interpretam exames de sangue de rotina e podem ajudar na detecção precoce do câncer de mama.